Skip to main content

Reporter

Clinical trial at VUMC tests novel treatment for asthma

Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

Read more


Study explores CVD risk for people with HIV

Nov. 10, 2022—A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.

Read more


Study defines role of steroids in congenital heart disease surgery

Nov. 10, 2022—Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now.

Read more


Kennedy Center seeks participants for disabilities research learning sessions

Nov. 10, 2022—In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.

Read more


Infectious Diseases Society of America honors Wright

Nov. 10, 2022—Vanderbilt's Patty Wright, MD, is one of two recipients of the 2022 Watanakunakorn Clinician Award from the Infectious Diseases Society of America.

Read more


Study to explore nasal bacteria of children born by C-section

Nov. 10, 2022—Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

Read more


Child passenger safety program receives funding from GM

Nov. 10, 2022—The Stay Seat Smart Program at Monroe Carell Jr. Children's Hospital at Vanderbilt recently received funding from General Motors to address child safety seat misuse through education, community outreach and media awareness.

Read more


Elam Lecture

Nov. 10, 2022—Tracy Gaudet, MD, recently delivered the third annual Dr. Roy O. Elam Memorial Lecture sponsored by the Osher Center for Integrative Medicine at Vanderbilt, the Department of Physical Medicine and Rehabilitation and the Vanderbilt Center for Musculoskeletal Research.

Read more


Alzheimer’s risk factor and cognition

Nov. 8, 2022—Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.

Read more


Gene mutations impair gut barrier

Nov. 7, 2022—Mutations in a cell membrane transporter protein impair the integrity of the gut lining, contributing to chronic gastrointestinal distress for people with the mutations, Vanderbilt researchers report.

Read more


Study finds Moderna’s COVID-19 vaccine safe and effective for young children

Nov. 4, 2022—A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.

Read more


C. diff infections drop in children

Nov. 3, 2022—The number of pediatric infections caused by Clostridioides difficile (C. diff) decreased from 2013 to 2019, likely due to an increase in antibiotic stewardship programs and improved hospital contact protocols, Vanderbilt researchers found.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more